GTS Securities’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Hold
0
1264
2024
Q3
Hold
0
1709
2024
Q2
Sell
-29,403
Closed -$83.5K 1566
2024
Q1
$83.5K Buy
29,403
+3,092
+12% +$8.78K ﹤0.01% 1277
2023
Q4
$387K Buy
+26,311
New +$387K ﹤0.01% 1026
2023
Q3
Hold
0
1403